Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel, a leading global provider of adhesives, sealants and functional coatings, today announced its membership with MedTech Europe, the industry association representing the medical technology sector in Europe. This collaboration aims to foster innovation and promote sustainable development in the value chains supporting the medical technology industry.

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums. The goal is to accelerate the adoption of innovative solutions, address industry challenges, and contribute to advancing the medical technology sector.

The partnership with MedTech Europe is part of the company’s broader strategy to strengthen its collaborations within the healthcare industry and ecosystem. By collaborating with industry associations, healthcare organizations, and technology providers, Henkel aims to drive innovation and create value for patients, healthcare professionals, and its partners throughout value chains.

“Joining forces with MedTech Europe is an exciting step for us. Together, we will be able to leverage our combined expertise to develop innovative solutions that address the ever-evolving needs of the medical technology industry,” said Dr. Philipp Loosen, Vice President and Head of Industrials EIMEA and Global Key Accounts Medical at Henkel Adhesive Technologies. “MedTech Europe represents the medical technology industry in Europe, covering a wide range of products, including medical devices, diagnostics, imaging equipment, and more.”

Chemical regulatory compliance is important to Henkel, and MedTech Europe provides multiple platforms to collaborate, contribute, and advocate the same through their working groups that deep dive into the aspects of sustainability, chemicals, and medical device regulations. “This is another milestone on our journey to becoming the key player in chemical regulatory compliance for our medical customers that contributes to sustainability and the environment,” said Senthil Pichandi, Vice President Global Product Safety and Regulatory Affairs (PSRA), Henkel Adhesive Technologies.

More here.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy